Healthcare Triangle is trading 10.09% down at $0.77 after opening-session weakness on September 4, 2026; no reliable company-specific catalyst has been identified.
- On September 3, Healthcare Triangle announced a planned Teyame AI separation, direct listing, and minority-interest stock distribution, but available coverage does not establish it as the cause.
- Broader markets are modestly lower, while software stocks are rising, providing limited explanatory support.